US Patent 9850262 Proteasome activity enhancing compounds
Patent 9850262 was granted and assigned to Proteostasis Therapeutics, Inc. on December, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+227 characters)
Article
Patent abstract
The present invention is directed to compounds having the Formula (I), (II), (III), (IV), and (V), compositions thereof, and methods for the treatment of a condition associated with a dysfunction in proteostasis.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Benito Munoz0
Bolin Geng0
Cecilia M. Bastos0
Markus Haeberlein0
Matthew Cullen0
Megan Foley0
Sheila Hauck0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09850262 Proteasome activity enhancing compounds US Patent 9850262 Proteasome activity enhancing compounds
Infobox
Patent Number
098502620
Patent Number
98502620
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098502620
Date of Patent
December 26, 2017
0Patent Application Number
151533790
Date Filed
May 12, 2016
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09850262 Proteasome activity enhancing compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09850262
Date of patent
December 26, 2017
Patent application number
15153379
Date Filed
May 12, 2016
Patent primary examiner
Find more entities like US Patent 9850262 Proteasome activity enhancing compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
